Liminal Biosciences Inc (LMNL)
6.70
0.00 (0.00%)
USD |
NASDAQ |
Jun 08, 14:33
Liminal Biosciences Price: 6.70 for June 8, 2023
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Jun 07, 2023 | 6.61 | 6.71 | 6.61 | 6.70 | 3928.00 |
| Jun 06, 2023 | 6.85 | 6.85 | 6.65 | 6.70 | 1969.00 |
| Jun 05, 2023 | 6.76 | 6.85 | 6.72 | 6.85 | 2945.00 |
| Jun 02, 2023 | 6.95 | 6.95 | 6.77 | 6.77 | 2684.00 |
| Jun 01, 2023 | 6.87 | 6.95 | 6.66 | 6.95 | 3375.00 |
| May 31, 2023 | 6.63 | 6.63 | 6.63 | 6.63 | 401.00 |
| May 30, 2023 | 6.91 | 6.91 | 6.59 | 6.90 | 9203.00 |
| May 26, 2023 | 6.930 | 6.94 | 6.908 | 6.94 | 2464.00 |
| May 25, 2023 | 6.840 | 6.95 | 6.840 | 6.95 | 2357.00 |
| May 24, 2023 | 6.89 | 6.95 | 6.89 | 6.95 | 3705.00 |
| May 23, 2023 | 6.88 | 6.90 | 6.80 | 6.90 | 3110.00 |
| May 22, 2023 | 6.80 | 6.831 | 6.774 | 6.774 | 1740.00 |
| May 19, 2023 | 6.80 | 6.83 | 6.776 | 6.81 | 2601.00 |
| May 18, 2023 | 6.74 | 6.75 | 6.73 | 6.75 | 3237.00 |
| May 17, 2023 | 6.72 | 6.821 | 6.66 | 6.737 | 6576.00 |
| May 16, 2023 | 6.785 | 6.855 | 6.76 | 6.76 | 2415.00 |
| May 15, 2023 | 6.95 | 6.95 | 6.82 | 6.820 | 3418.00 |
| May 12, 2023 | 6.95 | 6.95 | 6.88 | 6.94 | 1058.00 |
| May 11, 2023 | 6.829 | 6.98 | 6.780 | 6.80 | 18879.00 |
| May 10, 2023 | 6.77 | 6.85 | 6.73 | 6.84 | 6117.00 |
| May 09, 2023 | 6.760 | 6.80 | 6.640 | 6.77 | 8984.00 |
| May 08, 2023 | 6.79 | 6.79 | 6.59 | 6.78 | 15676.00 |
| May 05, 2023 | 6.69 | 6.78 | 6.57 | 6.75 | 3822.00 |
| May 04, 2023 | 6.58 | 6.690 | 6.55 | 6.660 | 2572.00 |
| May 03, 2023 | 6.64 | 6.72 | 6.597 | 6.645 | 1456.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.25
Minimum
Dec 30 2022
6840.71
Maximum
Jul 11 2018
618.33
Average
50.70
Median
Dec 21 2020
Price Benchmarks
| Acasti Pharma Inc | 0.4862 |
| Aurinia Pharmaceuticals Inc | 10.50 |
| Edesa Biotech Inc | 0.87 |
| Lexaria Bioscience Corp | 0.7506 |
| Xenon Pharmaceuticals Inc | 42.71 |
Price Related Metrics
| PE Ratio | 6.880 |
| PS Ratio | 51.59 |
| Price to Book Value | 0.968 |
| Earnings Yield | 14.53% |
| Market Cap | 20.80M |